Sagent Pharmaceuticals ($SGNT) is widening its recall of antibiotics manufactured by one of its India-based contractors after a customer complained that small…

Sun Pharma continues to slog away at its remediation efforts at both its key plant in Halol as well at the four plants it got in its $4 billion buyout of…

Portola has gotten an FDA CRL largely focused on manufacturing issues for AndexXa, its breakthrough anticoagulant reversal agent. It joins a number of other…

Pfizer has decided that it does not need the legacy distribution sites that it got with the $15 billion buyout of Hospira last year and so will close four…

Germany’s Fresenius Kabi will have more sterile injectable production capacity as it invests $250 million to turn a U.S. site into a showcase for its sterile…

Allergan, which this month completed the sale of its Actavis generics unit to Teva, is still cleaning up Actavis business, like the recall of tens of thousands…

The FDA has read the riot act to yet another Chinese drugmaker after finding it had been hiding batch tests results that showed high peaks of out-of-spec…

Piramal, like a number of its Indian compatriots, has decided it is a good idea to have manufacturing operations based in the U.S. and has now snapped up a…